# Technical Feasibility Evaluation of Mucosal Staining During Colon Capsule Endoscopy (CCE) Procedure in Colorectal Cancer (CRC) High Risk Population, When Using MB-MMX

> **NCT05022719** · NA · COMPLETED · sponsor: **Medtronic - MITG** · enrollment: 8 (actual)

## Conditions studied

- Colorectal Cancer
- Polyp, Colonic

## Interventions

- **DEVICE:** PillCam Colon2 procedure with MB-MMX

## Key facts

- **NCT ID:** NCT05022719
- **Lead sponsor:** Medtronic - MITG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-04
- **Primary completion:** 2022-09-28
- **Final completion:** 2022-09-28
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05022719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05022719, "Technical Feasibility Evaluation of Mucosal Staining During Colon Capsule Endoscopy (CCE) Procedure in Colorectal Cancer (CRC) High Risk Population, When Using MB-MMX". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05022719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*